We reported that CD19+ exosomes from B cells, through CD39 and CD73 vesicle-incorporated proteins, hydrolyzed ATP from chemotherapy-treated tumor cells into adenosine, thus impairing CD8+ T-cell responses [120]. This evidence concerns the gene CD8A and neoplasm.